Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2008
11/05/2008EP1986699A2 Rna interference agents for therapeutic use
11/05/2008EP1986697A2 Compositions and methods for inhibiting gene silencing by rna interference
11/05/2008EP1986693A1 A base forming drug-layered silicate hybrid containing basic polymer and its synthesis method
11/05/2008EP1986691A2 Antimicrobial formulations comprising a quinone and a copper salt
11/05/2008EP1986683A2 Compositions and methods for effecting controlled posterior vitreous detachment
11/05/2008EP1986670A2 Intestinal alpha-glucosidase inhibitors and a process for the isolation and use thereof
11/05/2008EP1986666A1 Novel method and compositions for treatment of tinnitus
11/05/2008EP1986665A2 Microalgae-derived compositions for improving the health and appearance of skin
11/05/2008EP1986664A1 Composition for treating cancer comprising oligonucleotide and non-toxic lps
11/05/2008EP1986663A2 Adenosine monophosphate for inducing torpor in a subject
11/05/2008EP1986662A2 Methods and compositions for ameliorating or inhibiting decline in memory or intelligence or improving same
11/05/2008EP1986661A2 Gene therapy for niemann-pick disease type a
11/05/2008EP1986660A2 Hexose compounds to treat cancer
11/05/2008EP1986659A2 Stable dosage formulations of imidazolylalkyl-pyridines
11/05/2008EP1986658A2 Ibandronate new regimen for treating metastatic bone pain
11/05/2008EP1986657A2 Method of treating a subject suffering from degenerative disc disease using a matrix metalloprotease inhibitor
11/05/2008EP1986656A2 Withacnistin compounds for treatment of cancer
11/05/2008EP1986655A2 Osteoporosis associated markers and methods of use thereof
11/05/2008EP1986654A2 Substituted taraxastanes useful for treating viral infections
11/05/2008EP1986653A1 The treatment of ocular conditions and the systemic side-effects of glucocorticoids
11/05/2008EP1986652A2 Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
11/05/2008EP1986651A1 Use of a pyrimidinedione derivative for preventing or treating hepatitis c
11/05/2008EP1986650A1 Tamper resistant dosage forms
11/05/2008EP1986648A2 Hydroxylamines and derivatives as anti-angiogenic agents
11/05/2008EP1986647A2 4-acylaminopyridine derivative mediated neurogenesis
11/05/2008EP1986646A1 Novel azacycly-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments
11/05/2008EP1986645A1 Glucokinase activators
11/05/2008EP1986644A1 Drug combinations for the treatment of respiratory tract diseases
11/05/2008EP1986643A1 Treatment of duchenne muscular dystrophy
11/05/2008EP1986641A1 Bladder cancer treatment involving determination of tumor enzyme level
11/05/2008EP1986640A1 Bladder cancer treatment by using e09 and propylene glycol
11/05/2008EP1986639A2 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of depression, anxiety, and neurodegenerative disorders
11/05/2008EP1986638A2 Cb1 antagonists and inverse agonists
11/05/2008EP1986637A1 Sulfonamide derivatives for the treatment of bacterial infections
11/05/2008EP1986636A2 Side chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
11/05/2008EP1986635A2 Anticancer agents
11/05/2008EP1986634A2 Synergistic pharmaceutical composition containing a peptide with 2 to 5 amino acids
11/05/2008EP1986633A2 Treatment of duchenne muscular dystrophy
11/05/2008EP1986632A1 Combinations comprising a cdk inhibitor and a growth factor antibody or anti-mitotic
11/05/2008EP1986631A2 Methoxypolyethylene glycol thioester chelate and uses thereof
11/05/2008EP1986630A2 A taxane derivative containing pharmaceutical composition with improved therapeutic efficacy
11/05/2008EP1986629A2 Platelet stabilization
11/05/2008EP1986628A2 Methods and compositions for treating hyperalgesia
11/05/2008EP1986627A2 Use of a compound that enhances gabaa-ergic neurotransmission for the treatment of inflammatory diseases
11/05/2008EP1986626A1 Intravenous antiviral treatments
11/05/2008EP1986625A1 Treatment of ovarian cancer
11/05/2008EP1986624A2 Method of using abscisic acid to treat and prevent diseases and disorders
11/05/2008EP1986623A2 Method for treatment of neuropathic pain
11/05/2008EP1986621A1 Use of resveratrol and derivatives thereof for promoting the wellness state in mammals
11/05/2008EP1986620A1 Methods and compositions for bactericide, bacteriostatic and anti-inflammation
11/05/2008EP1986619A2 Use of phosphatases to treat tumors overexpressing n-cor
11/05/2008EP1986618A2 Adhesive preparation comprising sufentanil and methods of using the same
11/05/2008EP1986610A1 Loading of hydrophobic drugs into hydrophilic polymer delivery systems
11/05/2008EP1986608A1 Pharmaceutical composition comprising amorphous atorvastatin
11/05/2008EP1986606A2 Phenylephrine-containing liquid formulations
11/05/2008EP1986529A2 Storage-stable oral dosage form of amoxicillin and clavulanic acid
11/05/2008EP1858901B1 Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives as antidiabetic compounds
11/05/2008EP1824844B1 Pyrazine dicarboxamides and the use thereof
11/05/2008EP1824479B1 Phenylpiperazine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition
11/05/2008EP1811979B1 Microcapsules comprising a methylxanthine and a corticosteroid
11/05/2008EP1781659B1 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
11/05/2008EP1781274B1 Novel biaromatic compounds which activate receptors of ppar type and their use in cosmetic or pharmaceutical compositions
11/05/2008EP1773890B1 Process for the preparation of low molecular weight heparin
11/05/2008EP1768665B1 Peptidomimetic inhibitors of hiv protease
11/05/2008EP1761515B1 2-(hetero-)aryl substituted tetrahydroquinoline derivatives
11/05/2008EP1732921B1 Thioamide derivatives as progesterone receptor modulators
11/05/2008EP1713781B1 Quinazoline derivatives
11/05/2008EP1709028B1 Fused heteroaryl derivatives and their use as p38 kinase inhibitors
11/05/2008EP1664032B1 N-substituted pyrazolyl-amidyl-benzimidazolyl c-kit inhibitors
11/05/2008EP1663970B1 Matrix metalloproteinase inhibitors
11/05/2008EP1646378B1 Pharmaceutical compositions comprising ascorbic acid for the treatment of fungal superfinfections and fungal recurrences
11/05/2008EP1638969B1 Cgrp receptor antagonists
11/05/2008EP1635830B1 Granulate formulation of the rapamycin ester cci-779
11/05/2008EP1622612B9 Pharmaceutical formulation of the sodium salt of telmisartan
11/05/2008EP1608663B1 Pyrrolo (2,1-c)(1,4) benzodiazepines dimers as antitumour agents and process thereof
11/05/2008EP1608374B1 2-phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
11/05/2008EP1605924B1 Mesoprogestins (progesterone receptor modulators) as a component of compositions for hormone replacement therapy (hrt)
11/05/2008EP1604660B1 Medicinal composition for treating infection with drug-resistant staphylococcus aureus
11/05/2008EP1597258B1 Novel purine derivatives, preparation method thereof, application of same as medicaments, pharmaceutical compositions and novel use
11/05/2008EP1551390A4 Levamisole, avermectins or similar in pyrrolidone solvent
11/05/2008EP1549246A4 Antibiotic microspheres for treatment of infections and osteomyelitis
11/05/2008EP1534276B1 Non-nucleoside reverse transcriptase inhibitors
11/05/2008EP1505945B1 Substituted cycloalkyl p1' hepatitis c virus inhibitors
11/05/2008EP1499596B1 Muscarinic antagonists
11/05/2008EP1496859B1 Aqueous formulations of (2-hydroxymethyl-indanyl-4-oxy)-phenyl-4,4,4-trifluorobutane-1-sulfonate
11/05/2008EP1487828B1 Morpholinyl-urea derivatives for use of the treatment of inflamatory diseases
11/05/2008EP1465876B1 Long chain fatty alcohol substituents in antineoplastic agents
11/05/2008EP1448215B1 Use of laminarin in the treatment of cancer
11/05/2008EP1404311B1 Wound treatment agent
11/05/2008EP1385514B1 Spiroindene and spiroindane compounds
11/05/2008EP1383500A4 Composition and method for the treatment of respiratory disease
11/05/2008EP1372671B1 Methylation modulating agents for intraductal treatment of breast cancer
11/05/2008EP1355634B1 Sn-38 lipid complexes and methods of use
11/05/2008EP1345630B1 Stabilised radiopharmaceutical compositions
11/05/2008EP1341811B9 Orally ingestible preparation of mistletoe lectins and method
11/05/2008EP1324970B1 Retinoids for the treatment of emphysema
11/05/2008EP1319000B1 Use of 1-azabicyclo 2.2.2 octan-3-one derivatives for treating cancer tumors
11/05/2008EP1309544B1 Compounds acting as melanocortin receptor ligands
11/05/2008EP1303278B1 Combination of a transdermal therapeutic system and an oral and/or parenteral preparation containing dopamine agonists for the treatment of dopaminergic disease states
11/05/2008EP1296973B1 Guanidine derivatives of quinazoline for use in the treatment of autoimmune diseases
1 ... 3011 3012 3013 3014 3015 3016 3017 3018 3019 3020 3021 3022 3023 3024 3025 3026 3027 3028 3029 3030 3031 ... 7860